000 01503cam  2200313za 4500
0019.866237
003CaOODSP
00520221107162010
007cr |||||||||||
008190115s2019    oncd    o    f000 0 eng d
020 |a9780660290560
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH82-31/2019E-PDF
24504|aThe market for prescription oral solid opioids, 2010 to 2017 |h[electronic resource] : |pCanada and the United States.
260 |aOttawa : |bPatented Medicine Prices Review Board, |cc2019.
300 |a43 p. : |bcol. charts
500 |aIssued also in French under title: Le marché des opioïdes d’ordonnance sous forme orale solide, de 2010 à 2017 : Canada et États-Unis.
500 |aCover title.
500 |aIssued also in HTML format.
504 |aIncludes bibliographic references.
520 |a"To provide an overview of the market for prescription opioids in Canada and the United States to inform discussions on the impact of the proposed regulatory changes"--Purpose of this analysis, p. 5.
69207|2gccst|aPrescription drugs
693 4|aOpioids
7101 |aCanada. |bPatented Medicine Prices Review Board.
77508|tLe marché des opioïdes d’ordonnance sous forme orale solide, de 2010 à 2017 |w(CaOODSP)9.866239
85640|qPDF|s894 KB|uhttps://publications.gc.ca/collections/collection_2019/cepmb-pmprb/H82-31-2019-eng.pdf
8564 |qHTML|sN/A|uhttp://www.pmprb-cepmb.gc.ca/view.asp?ccid=1417&lang=en